You can change the landscape of dementia research.
Last year we celebrated a huge development in dementia research. For the first time, there are two drugs – donanemab and lecanemab – that can slow down the progress of Alzheimer’s disease. We urgently need to continue this research in time to benefit the 1 in 3 people born today who will develop dementia.
It was thanks to supporters like you, that researchers discovered the link between amyloid protein build-up and Alzheimer’s disease over thirty years ago, laying the groundwork for drugs like donanemab and lecanemab.